Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
Mechanisms for marking the orientation of a sawed die
Device chip carriers, modules, and methods of forming thereof
Arbitration for memory device with commands
Mobile terminal and method for displaying information
Touch screen guitar
Knife grip
Method and device for managing a turning setpoint applied to at least one turning actuator for the rear wheels of an automobile
  Randomly Featured Patents
Universal tie-less patient limb restraint device
Abrasive glove
Method of use of an analog of Haemophilus influenzae Hin47 with reduced protease activity
Voltage regulator with drive override
Surgical needle holder
Bright light indicator
Reaction bonded silicon nitride
Signal processing for optical computing system
Injection device
High voltage operating rod sensor and method of making the same